95-15923. Antibiotic Drugs; Cefotetan and Cefotetan Disodium Injection; Technical Amendments  

  • [Federal Register Volume 60, Number 125 (Thursday, June 29, 1995)]
    [Rules and Regulations]
    [Page 33712]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-15923]
    
    
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    21 CFR Part 442
    
    [Docket No. 94N-0132]
    
    
    Antibiotic Drugs; Cefotetan and Cefotetan Disodium Injection; 
    Technical Amendments
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; technical amendments.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is technically amending 
    a final rule that appeared in the Federal Register of May 25, 1994 (59 
    FR 26939). The document amended the antibiotic drug regulations to 
    provide for the inclusion of accepted standards for a new bulk form of 
    cefotetan. The agency received a comment on the final rule that pointed 
    out, among other things, that the correct name of the antibiotic is 
    cefotetan disodium. This document corrects those errors.
    
    EFFECTIVE DATE: June 29, 1995.
    
    FOR FURTHER INFORMATION CONTACT: James M. Timper, Center for Drug 
    Evaluation and Research (HFD-520), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-443-6714.
    
    SUPPLEMENTARY INFORMATION: As published, the final regulation contains 
    errors that may prove to be misleading and are in need of 
    clarification. The name of the antibiotic is ``cefotetan disodium'' not 
    ``cefotetan sodium.'' The calculation for determining cefotetan 
    concentration in the finished dosage form was published incorrectly, 
    and an additional sample preparation, potassium bromide discs, can be 
    used also. Accordingly the agency is amending 21 CFR 442.52 to correct 
    those errors.
    
    List of Subjects in 21 CFR Part 442
    
        Antibiotics.
    
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
    442 is amended as follows:
    
    PART 442--CEPHA ANTIBIOTIC DRUGS
    
        1. The authority citation for 21 CFR part 442 continues to read as 
    follows:
    
        Authority: Sec. 507 of the Federal Food, Drug, and Cosmetic Act 
    (21 U.S.C. 357).
    
        2. Section 442.52 is amended by revising paragraphs (b)(1)(iv) and 
    (b)(3) to read as follows:
    
    Sec. 442.52  Cefotetan.
    
        (b) * * *
        (1) * * *
        (iv) Calculation. Calculate the micrograms of cefotetan per 
    milligram of sample as follows:
    
    
                                                                            
                                                       AU X PS X Vf X 1,000 
    Micrograms of cefotetan             =            -----------------------
         per milligram                                        AS X Vs       
                                                                            
    
    where:
    AU = Area of the cefotetan peak in the chromatogram of the 
    sample (at a retention time equal to that observed for the 
    standard);
    AS = Area of the cefotetan peak in the chromatogram of the 
    cefotetan working standard;
    PS = Cefotetan activity in the cefotetan working standard 
    solution in micrograms per milliliter;
    Vf = Volume of flask used to dilute standard; and
    Vs = Volume of sample diluted.
    * * * * *
        (3) Identity. Proceed as directed in Sec. 436.211 of this chapter 
    using the potassium bromide discs prepared as described in 
    Sec. 436.211(b)(1) of this chapter or the mineral oil mull prepared as 
    described in Sec. 436.211(b)(2) of this chapter.
        Dated: May 9, 1995.
    Murray M. Lumpkin,
    Deputy Director, Center for Drug Evaluation and Research.
    [FR Doc. 95-15923 Filed 6-28-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Effective Date:
6/29/1995
Published:
06/29/1995
Department:
Health and Human Services Department
Entry Type:
Rule
Action:
Final rule; technical amendments.
Document Number:
95-15923
Dates:
June 29, 1995.
Pages:
33712-33712 (1 pages)
Docket Numbers:
Docket No. 94N-0132
PDF File:
95-15923.pdf
CFR: (2)
21 CFR 436.211(b)(1)
21 CFR 442.52